Breast Cancer Research 2010

Scientific Programme

We are pleased to announce an exciting programme of speakers and over 60 poster presentations that will encompass all aspects of breast cancer research, from prevention right through to treatment and beyond.

Agenda (subject to change)

Morning
09.00-10.00	Registration, coffee and posters

10.00-10.05	Chief Executive’s welcome: Pamela Goldberg

10.05-10.10	Morning session introduction, Dr Suzanne Eccles, Chair, Campaign Scientific Advisory Board and invited guest speaker (tbc)

10.10-10.20	Professor Alastair Thompson, University of Dundee, ‘Introduction to the tissue bank’

10.20-10.55	Keynote: Dr W. Fraser Symmans, MD Anderson Cancer Center, University of Texas, ‘Tissue banking’ (title tbc)

10.55-11.15	Abstract speaker: Dr Valerie Speirs, Leeds Institute of Molecular Medicine, University of Leeds, ‘Male versus female breast cancer: a comparative study of 523 matched cases reveals differences behind similarity’

11.15-11.45	*Coffee break*

11.45-12.20	Keynote: Professor John Bartlett, University of Edinburgh, ‘Biomarkers for the diagnosis and prediction of therapeutic response in clinical breast cancer’

12.20-12.40	Abstract speaker: Dr Anthony Kong, University of Oxford, ‘Upregulation of ADAM proteases and HER ligands through a feedback loop mediates acquired resistance to Trastuzumab in HER2 amplified breast cancer’

12.40-14.25	Lunch and posters

Afternoon
14.25-14.35	Chair’s introduction and presentation of Emerging Investigator’s Poster Prize, Professor Gareth Evans, Deputy Chair, Campaign Scientific Advisory Board

14.35-14.55	Abstract speaker: Dr Jo Morris, King’s College London, ‘New regulators of the BRCA1 response to genotoxic stress’

14.55-15.15	Abstract speaker: Dr James Flanagan, Imperial College London, ‘DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status’

15.15-15.35	Abstract speaker: Dr Gillian Farnie, University of Manchester, ‘Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radio and chemotherapy’

15.35-16.00	Tea break

16.00-16.20	Abstract speaker: Professor Clare Isacke, Institute of Cancer Research, London, ‘The transforming growth factor-β co-receptor endoglin suppresses breast cancer invasion and metastasis’

16.20-16.55	Keynote: Professor Robert Coleman, Weston Park Hospital, Sheffield, ‘Recent advances in treatment of metastatic breast cancer’

16.55-17.00	Close